You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康華生物(300841.SZ):公司近年產能利用率處於較高水平
格隆匯 07-22 18:30

格隆匯7月22日丨康華生物(300841.SZ)在投資者互動平台表示,公司近年產能利用率處於較高水平。人用狂犬病疫苗每年使用量巨大,人二倍體狂犬病疫苗在狂犬病疫苗市場中的佔比相對較小,以其採用人二倍體細胞為細胞基質培養狂犬病病毒等的差異化優勢,對其他細胞基質狂犬病疫苗形成的補充空間較大。公司凍幹人用狂犬病疫苗(人二倍體細胞)具有“無引入動物源細胞殘留DNA和動物源細胞蛋白”、安全性高、免疫原性好、保護持續時間長等的產品優勢,自2014年上市以來銷售規模持續擴大,積累了豐富的臨牀使用經驗,此外,公司與重要客户建立了良好的合作,並持續開展疫苗產品免疫原性、安全性以及免疫持久性和加強免疫等研究,以強有力的學術支持提高公司產品的市場認知度、建立品牌影響力,公司將持續拓展營銷渠道,提高營銷管理水平,促進公司業務發展。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account